Mistras’ appointment goes into effect at the end of May. She succeeds Scott Ullem, who announced his intent to depart the company in October 2025.
Prior to joining Edwards, Mistras served as CFO at pharmaceutical company Viatris. Holding that post since March 2024, she led Viatris’ global finance organization and oversaw financial planning, reporting and operational finance.
Before Viatris, she served as a managing director in healthcare investment banking at Citigroup Global Markets. Prior to that, Mistras held senior leadership roles in healthcare investment banking at Goldman Sachs.
Edwards says Mistras brings decades of healthcare leadership experience across corporate finance, strategy and investor relations.
“We are very pleased to welcome Doretta to Edwards as our next CFO,” said Bernard Zovighian, Edwards’ CEO. “Doretta’s broad experience will be instrumental as we execute our differentiated strategy. We look forward to her leadership as we continue to invest in innovation, and also deliver distinguished and durable financial results and long-term value to patients, customers, shareholders and the broader healthcare ecosystem.”
Ullem intends to continue as a strategic advisor for the Irvine, California–based heart valve maker. He departs after more than a decade in the CFO post, joining in 2014.
“We would like to once again thank Scott for his outstanding leadership, partnership and impact,” Zovighian said. “His commitment to a thoughtful transition and his continued support as a strategic advisor in the months ahead reflects the discipline and continuity that have long defined Edwards’ approach to leadership. We are grateful for Scott’s numerous contributions over the years that have helped to strengthen our company both strategically and financially.”
